Xanthine-13C,15N2
Modify Date: 2024-01-12 10:45:58
Xanthine-13C,15N2 structure
|
Common Name | Xanthine-13C,15N2 | ||
|---|---|---|---|---|
| CAS Number | 1262670-81-4 | Molecular Weight | 155.09 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C413CH4N215N2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Xanthine-13C,15N2Xanthine-13C,15N2 is a 15N-labeled and 13C-labled Deruxtecan. Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and amaleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402. |
| Name | Xanthine-¹³C¹⁵N2 |
|---|---|
| Synonym | More Synonyms |
| Description | Xanthine-13C,15N2 is a 15N-labeled and 13C-labled Deruxtecan. Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and amaleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[75]. |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Molecular Formula | C413CH4N215N2O2 |
| Molecular Weight | 155.09 |
| Exact Mass | 155.030853 |
| Index of Refraction | 1.636 |
| (2-13C,1,3-15N2)-3,9-Dihydro-1H-purine-2,6-dione |
| 1H-Purine-2,6-dione-2-13C-1,3-15N2, 3,9-dihydro- |
| Xanthic oxide-13C15N2 |
| 1H-Purine-2,6-diol |